Wall Street Breakfast
2404 - Bristol-Myers wins FDA nod for novel antipsychotic
2404 - Bristol-Myers wins FDA nod for novel antipsychotic
Seeking Alpha's flagship Wall Street Breakfast provides investors an overview of key investment news every morning and afternoon.
Transcripts: seekingalpha.com/wsb
More episodes
-
2404 - Bristol-Myers wins FDA nod for novel antipsychoticFri, 27 Sep 2024
-
2403 - Micron renews AI chip enthusiasmThu, 26 Sep 2024
-
2402 - OpenAI eyes restructure, Murati exitsThu, 26 Sep 2024
-
2401 - American ISPs targeted by new hacker groupWed, 25 Sep 2024
-
2400 - Stitch Fix sinks after Q4 sales drop, gloomy outlookWed, 25 Sep 2024
Vis flere episoder
5
Flere nyheder og politik podcasts
Flere nyheder og politik podcasts
Find din radiostation